Abbott Debt Ratio from 2010 to 2025

ABT Stock

USD 126.34 0.44 0.35%

Abbott Laboratories Debt Ratio yearly trend continues to be comparatively stable with very little volatility. Debt Ratio will likely drop to 0.18 in 2025. From the period from 2010 to 2025, Abbott Laboratories Debt Ratio quarterly data regression had r-value of (0.06) and coefficient of variation of 29.29. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

0.18450144

Current Value

0.18

Quarterly Volatility

0.07286834

Credit Downgrade

Yuan Drop

Covid

Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 B, Interest Expense of 531 M or Selling General Administrative of 6.4 B, as well as many indicators such as Price To Sales Ratio of 4.9, Dividend Yield of 0.0186 or PTB Ratio of 2.63. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.

Check out the analysis of Abbott Laboratories Correlation against competitors.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Latest Abbott Laboratories' Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Abbott Laboratories over the last few years. It is Abbott Laboratories' Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abbott Laboratories' overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

Abbott Debt Ratio Regression Statistics

	Arithmetic Mean	0.25
	Geometric Mean	0.24
	Coefficient Of Variation	29.29
	Mean Deviation	0.06
	Median	0.25
	Standard Deviation	0.07
	Sample Variance	0.01
	Range	0.2651
	R-Value	(0.06)
	Mean Square Error	0.01
	R-Squared	0
	Significance	0.81
	Slope	(0.001)
	Total Sum of Squares	0.08

Abbott Debt Ratio History

	2024	0.18
	2022	0.24
	2021	0.25
	2020	0.27
	2019	0.28
	2018	0.29
	2017	0.37

Other Fundumenentals of Abbott Laboratories

Cash Flow To Debt Ratio

Abbott Laboratories Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Current Deferred Revenue	Short Term Investments	Common Stock	Intangible Assets	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Long Term Debt Total	Long Term Investments	Accumulated Depreciation	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.92	0.65	0.82	0.86	0.79	0.6	-0.13	0.84	-0.68	-0.13	-0.01	0.61	0.7	-0.69	0.84	0.84	-0.09	0.58	-0.22	-0.53	0.37	-0.69	-0.27	-0.36	0.58
Total Stockholder Equity	0.92		0.4	0.95	0.88	0.51	0.42	-0.05	0.88	-0.73	-0.14	-0.12	0.38	0.4	-0.69	0.81	0.73	0.17	0.34	-0.21	-0.52	0.43	-0.67	-0.14	-0.34	0.79
Net Debt	0.65	0.4		0.17	0.36	0.8	0.25	-0.42	0.46	-0.28	-0.19	0.01	0.97	0.8	-0.37	0.53	0.83	-0.71	0.7	-0.27	-0.2	-0.03	-0.72	-0.57	-0.58	-0.04
Retained Earnings	0.82	0.95	0.17		0.82	0.36	0.4	0.07	0.79	-0.73	-0.17	-0.17	0.14	0.27	-0.71	0.7	0.54	0.38	0.21	-0.01	-0.43	0.5	-0.51	0.02	-0.21	0.83
Net Receivables	0.86	0.88	0.36	0.82		0.53	0.51	0.06	0.73	-0.42	0.05	0.22	0.29	0.37	-0.34	0.81	0.62	0.12	0.33	-0.33	-0.68	0.27	-0.46	0.03	-0.19	0.7
Total Liab	0.79	0.51	0.8	0.36	0.53		0.75	-0.21	0.55	-0.43	-0.06	0.12	0.74	0.88	-0.53	0.71	0.81	-0.41	0.69	-0.2	-0.36	0.21	-0.49	-0.41	-0.29	0.0
Total Current Assets	0.6	0.42	0.25	0.4	0.51	0.75		0.19	0.32	-0.37	0.34	0.16	0.15	0.55	-0.38	0.55	0.39	0.1	0.34	-0.15	-0.35	0.3	0.04	0.03	0.17	0.02
Short Term Debt	-0.13	-0.05	-0.42	0.07	0.06	-0.21	0.19		-0.31	-0.06	0.43	0.33	-0.39	-0.5	0.08	-0.22	-0.37	0.4	-0.71	-0.06	0.21	0.02	0.56	0.41	0.4	-0.08
Accounts Payable	0.84	0.88	0.46	0.79	0.73	0.55	0.32	-0.31		-0.63	-0.36	-0.16	0.45	0.45	-0.66	0.88	0.84	0.1	0.43	-0.24	-0.7	0.49	-0.81	-0.46	-0.46	0.74
Current Deferred Revenue	-0.68	-0.73	-0.28	-0.73	-0.42	-0.43	-0.37	-0.06	-0.63		0.2	0.24	-0.35	-0.33	0.86	-0.48	-0.53	-0.21	-0.14	0.03	0.0	-0.42	0.54	0.31	0.34	-0.45
Short Term Investments	-0.13	-0.14	-0.19	-0.17	0.05	-0.06	0.34	0.43	-0.36	0.2		0.07	-0.23	-0.22	0.35	-0.16	-0.27	0.15	-0.35	-0.27	0.04	-0.29	0.48	0.28	0.32	-0.28
Common Stock	-0.01	-0.12	0.01	-0.17	0.22	0.12	0.16	0.33	-0.16	0.24	0.07		0.0	-0.05	0.43	0.05	-0.05	-0.15	-0.11	-0.18	-0.18	-0.16	0.28	0.16	0.18	-0.17
Intangible Assets	0.61	0.38	0.97	0.14	0.29	0.74	0.15	-0.39	0.45	-0.35	-0.23	0.0		0.75	-0.41	0.44	0.79	-0.75	0.64	-0.25	-0.11	-0.05	-0.74	-0.61	-0.56	-0.03
Long Term Debt	0.7	0.4	0.8	0.27	0.37	0.88	0.55	-0.5	0.45	-0.33	-0.22	-0.05	0.75		-0.48	0.49	0.67	-0.53	0.92	-0.01	-0.21	0.17	-0.53	-0.35	-0.29	0.03
Treasury Stock	-0.69	-0.69	-0.37	-0.71	-0.34	-0.53	-0.38	0.08	-0.66	0.86	0.35	0.43	-0.41	-0.48		-0.49	-0.6	-0.08	-0.3	-0.26	0.03	-0.44	0.57	0.36	0.33	-0.4
Property Plant Equipment	0.84	0.81	0.53	0.7	0.81	0.71	0.55	-0.22	0.88	-0.48	-0.16	0.05	0.44	0.49	-0.49		0.88	0.03	0.45	-0.37	-0.75	0.41	-0.64	-0.31	-0.36	0.52
Good Will	0.84	0.73	0.83	0.54	0.62	0.81	0.39	-0.37	0.84	-0.53	-0.27	-0.05	0.79	0.67	-0.6	0.88		-0.32	0.58	-0.35	-0.54	0.28	-0.83	-0.58	-0.56	0.34
Net Tangible Assets	-0.09	0.17	-0.71	0.38	0.12	-0.41	0.1	0.4	0.1	-0.21	0.15	-0.15	-0.75	-0.53	-0.08	0.03	-0.32		-0.51	0.14	-0.18	0.44	0.28	0.28	0.21	0.45
Long Term Debt Total	0.58	0.34	0.7	0.21	0.33	0.69	0.34	-0.71	0.43	-0.14	-0.35	-0.11	0.64	0.92	-0.3	0.45	0.58	-0.51		-0.01	-0.3	0.19	-0.55	-0.25	-0.27	0.13
Long Term Investments	-0.22	-0.21	-0.27	-0.01	-0.33	-0.2	-0.15	-0.06	-0.24	0.03	-0.27	-0.18	-0.25	-0.01	-0.26	-0.37	-0.35	0.14	-0.01		0.44	0.05	0.2	0.15	0.13	-0.09
Accumulated Depreciation	-0.53	-0.52	-0.2	-0.43	-0.68	-0.36	-0.35	0.21	-0.7	0.0	0.04	-0.18	-0.11	-0.21	0.03	-0.75	-0.54	-0.18	-0.3	0.44		-0.33	0.37	0.22	0.15	-0.57
Short Long Term Debt	0.37	0.43	-0.03	0.5	0.27	0.21	0.3	0.02	0.49	-0.42	-0.29	-0.16	-0.05	0.17	-0.44	0.41	0.28	0.44	0.19	0.05	-0.33		-0.28	-0.07	-0.17	0.45
Cash And Equivalents	-0.69	-0.67	-0.72	-0.51	-0.46	-0.49	0.04	0.56	-0.81	0.54	0.48	0.28	-0.74	-0.53	0.57	-0.64	-0.83	0.28	-0.55	0.2	0.37	-0.28		0.67	0.8	-0.49
Net Invested Capital	-0.27	-0.14	-0.57	0.02	0.03	-0.41	0.03	0.41	-0.46	0.31	0.28	0.16	-0.61	-0.35	0.36	-0.31	-0.58	0.28	-0.25	0.15	0.22	-0.07	0.67		0.78	0.05
Net Working Capital	-0.36	-0.34	-0.58	-0.21	-0.19	-0.29	0.17	0.4	-0.46	0.34	0.32	0.18	-0.56	-0.29	0.33	-0.36	-0.56	0.21	-0.27	0.13	0.15	-0.17	0.8	0.78		-0.16
Capital Stock	0.58	0.79	-0.04	0.83	0.7	0.0	0.02	-0.08	0.74	-0.45	-0.28	-0.17	-0.03	0.03	-0.4	0.52	0.34	0.45	0.13	-0.09	-0.57	0.45	-0.49	0.05	-0.16

Click cells to compare fundamentals

About Abbott Laboratories Financial Statements

Abbott Laboratories shareholders use historical fundamental indicators, such as Debt Ratio, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in Abbott Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on Abbott Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Debt Ratio	0.18	0.18
Cash Flow To Debt Ratio	0.57	0.91

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Abbott Debt Ratio from 2010 to 2025

Latest Abbott Laboratories' Debt Ratio Growth Pattern

Abbott Debt Ratio Regression Statistics

Abbott Debt Ratio History

Other Fundumenentals of Abbott Laboratories

Abbott Laboratories Debt Ratio component correlations

About Abbott Laboratories Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Abbott Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY